|
Market Closed -
Nasdaq
02:30:00 12/11/2026 am IST
|
5-day change | 1st Jan Change | ||
| 64.91 USD | +1.20% |
|
-5.89% | -14.55% |
| 03/11 | PTC Therapeutics Approves $500 Million Share Repurchase Program | MT |
| 03/11 | PTC Therapeutics, Inc. authorizes a Buyback Plan. | CI |
| Market Cap | 542.29Cr 488.76Cr 451.56Cr 408.21Cr 772.3Cr 51TCr 791.36Cr 5.41TCr 2.16TCr 27TCr 2.04TCr 1.99TCr 87TCr | P/E 2026 * |
97.4x | P/E 2027 * | 23.5x |
|---|---|---|---|---|---|
| Enterprise Value | 363.39Cr 327.53Cr 302.59Cr 273.55Cr 517.53Cr 34TCr 530.3Cr 3.63TCr 1.45TCr 18TCr 1.36TCr 1.33TCr 58TCr | EV / Sales 2026 * |
2.75x | EV / Sales 2027 * | 2.34x |
| Free-Float |
92.7% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| PTCT | Delayed | |
CBOE
| PTCT | Real-time | |
|
Xetra
| BH3 | Delayed | |
|
Deutsche Boerse AG
| BH3 | Delayed | |
|
Tradegate
| BH3 | Real-time | |
|
Börse Stuttgart
| BH3 | Delayed | |
|
Boerse Muenchen
| BH3 | Real-time |
Last Transcript: PTC Therapeutics, Inc.
| 1 day | +1.20% | ||
| 1 week | -5.89% | ||
| Current month | +8.24% | ||
| 1 month | +0.32% | ||
| 3 months | -11.93% | ||
| 6 months | -15.54% | ||
| Current year | -14.55% |
| 1 week | 63.52 |  | 66.9 |
| 1 month | 58.8 | | 70.11 |
| Current year | 58.8 | | 90.87 |
| 1 year | 58.8 | | 90.87 |
| 3 years | 18.15 | | 90.87 |
| 5 years | 17.53 | | 90.87 |
| 10 years | 8.12 | | 90.87 |
| Manager | Title | Age | Since |
|---|---|---|---|
Matthew Klein
CEO | Chief Executive Officer | 54 | 22/03/2023 |
Pierre Gravier
DFI | Director of Finance/CFO | 41 | 13/07/2023 |
| Chief Tech/Sci/R&D Officer | - | 01/10/2017 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 74 | 01/11/2004 | |
Allan Jacobson
CHM | Chairman | 80 | 31/03/1998 |
David Southwell
BRD | Director/Board Member | 65 | 01/12/2005 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 14/10/26 | Other | Chairman | 0 | 0.0000% | ||
| 14/10/26 | Section Six Partners
| Sell | Company | -2,500 | 0.0030% | |
| 09/10/26 | Exercice | General Counsel | 576 | 0.0007% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.20% | -5.89% | -12.07% | +250.11% | 542.29Cr | |
| +0.35% | +1.36% | +45.38% | +140.47% | 1,28000Cr | |
| -0.13% | +1.48% | +44.67% | +90.43% | 68TCr | |
| +0.37% | +0.05% | +31.00% | +112.84% | 52TCr | |
| +0.02% | +1.52% | +39.21% | +69.76% | 39TCr | |
| -0.59% | -2.11% | +61.83% | +45.16% | 36TCr | |
| -1.29% | -1.13% | +27.54% | +58.29% | 30TCr | |
| +0.09% | -0.91% | +3.19% | +37.72% | 29TCr | |
| +0.62% | -2.17% | +38.31% | +75.12% | 25TCr | |
| -0.67% | -2.72% | +38.49% | +123.56% | 21TCr | |
| Average | +0.16% | -1.05% | +31.75% | +100.35% | 43TCr | |
| Weighted average by Cap. | +0.47% | +0.19% | +39.45% | +97.56% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 131.97Cr 118.95Cr 109.89Cr 99Cr 187.95Cr 12TCr 192.59Cr 1.32TCr 524.92Cr 6.63TCr 495.3Cr 484.76Cr 21TCr | 142.91Cr 128.8Cr 119Cr 107.58Cr 203.52Cr 13TCr 208.55Cr 1.43TCr 568.42Cr 7.18TCr 536.34Cr 524.93Cr 23TCr |
| Net income | 5.71Cr 5.15Cr 4.76Cr 4.3Cr 8.13Cr 535.74Cr 8.34Cr 57Cr 23Cr 286.92Cr 21Cr 21Cr 913.09Cr | 24Cr 22Cr 20Cr 18Cr 35Cr 2.28TCr 35Cr 242.12Cr 97Cr 1.22TCr 91Cr 89Cr 3.88TCr |
| Net Debt | -178.89Cr -161.24Cr -148.96Cr -134.66Cr -254.77Cr -17TCr -261.06Cr -1.79TCr -711.55Cr -8.99TCr -671.39Cr -657.11Cr -29TCr | -208.2Cr -187.65Cr -173.36Cr -156.72Cr -296.5Cr -20TCr -303.82Cr -2.08TCr -828.11Cr -10TCr -781.37Cr -764.75Cr -33TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/26/11 | $64.91 | +1.20% | 7,24,937 |
| 10/26/10 | $64.14 | -1.37% | 6,30,008 |
| 09/26/09 | $65.03 | -0.63% | 8,43,279 |
| 06/26/06 | $65.44 | -0.35% | 8,98,968 |
| 05/26/05 | $65.67 | -4.78% | 12,38,536 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- PTCT Stock
Select your edition
All financial news and data tailored to specific country editions
